The Progressive Corporation

Progressive's strong May operating update demonstrated faster premium growth, higher earnings, and superior underwriting profitability versus the prior year. Bank of America maintained a buy rating with a $308 price target, reflecting confidence in the company's pricing discipline and its ability to sustain healthy underwriting margins going forward.

Analyst consensus EPS estimates for Q2 2026 dropped sharply from $4.88 to $4.58, with full-year 2026 estimates falling from $18.25 to $17.30. Morgan Stanley assigned an underweight rating with a $190 price target, and Wells Fargo maintained a sell rating at $198, both citing deteriorating margin prospects and competitive pressure in the auto insurance market.

Progressive's revenue is forecast to grow at 6.1% per annum over the next three years, more than double the 2.7% growth forecast for the broader U.S. insurance industry. This outperformance signals a durable competitive advantage in policy growth and market share expansion that supports a premium valuation.

Despite the longer-term growth forecast, Progressive's Q2 2026 revenue of $22.19 billion missed analyst expectations of $23.51 billion by a significant margin. BMO Capital cut its price target to $205 and KBW lowered its target to $226, both with market-perform ratings, suggesting the revenue growth story is losing near-term credibility.

Goldman Sachs maintained a buy rating with a $225 price target, Piper Sandler kept an overweight rating at $241, and Bank of America's $308 target implies over 50% upside. These firms argue that Progressive's market leadership in auto insurance and disciplined underwriting justify a premium multiple relative to peers.

The analyst price target range spans from $190 to $308, reflecting deep disagreement about intrinsic value. With 16 of 25 analysts rating the stock a hold and the consensus at neutral, many believe the stock is operating in highly speculative valuation territory, with insider selling and softer revenue adding further downside risk.